LEE TIEN-LI (Chief Executive Officer) purchased 0.7% of their position (10K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $96.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/16/2025ACC: 0001193125-25-204233
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
+10K
Net shares
Net buyer
$96.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
$9.51
Trade value
$61.82K
% of position
0.4%
9/15/2025
1.53M→1.54M
Common Stock
Direct
Shares
+3.50K
Price / share
$9.94
Trade value
$34.80K
% of position
0.2%
9/15/2025
1.54M→1.54M
Total
Net shares
+10K
Net value
$96.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2025 | P · Purchase | +6.50K | $9.51 | $61.82K | 0.4% | 1.53M | 1.54M |
| Common Stock Direct | 9/15/2025 | P · Purchase | +3.50K | $9.94 | $34.80K | 0.2% | 1.54M | 1.54M |
| Total | +10K | $96.62K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.47M
Total
1.47M indirect1.47M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.47M | Indirect |
| Total | 1.47M | 1.47M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported